Market Overview

The Daratumumab market is predicted to develop at a compound annual growth rate (CAGR) of XX% from 2024 to 2034, when it is projected to reach USD XX Million, based on an average growth pattern. The market is estimated to reach a value of USD XX Million in 2024.

SOURCE: We Market Research

A monoclonal antibody called Daratumumab is used to treat the cancerous disease known as multiple myeloma. It helps destroy myeloma cells by targeting CD38, a protein present on their surface. Daratumumab either directly destroys cancer cells by attaching to CD38 or strengthens the immune system's defenses against them. It has demonstrated efficacy in enhancing patient outcomes and is frequently used in conjunction with other cancer therapy. Although Daratumumab selectively targets cancer cells while causing the least amount of damage to healthy organs, it represents a substantial development in the treatment of multiple myeloma and gives patients hope.

The Daratumumab market is driven by a number of important variables worldwide. The increasing global prevalence of multiple myeloma is driving up demand for targeted treatments such as Daratumumab.  Improvements in biotechnology, especially in the field of developing monoclonal antibodies, have made it possible to design more targeted and efficient therapeutic interventions. The market is also growing as a result of Daratumumab's extended approvals for diseases other than multiple myeloma, namely lymphoma and amyloidosis. Adoption of Daratumumab is further encouraged by strong clinical evidence demonstrating its safety and efficacy in multiple myeloma, particularly when used in combination treatments. Moreover, rising healthcare spending around the world promotes patient access to Daratumumab, which in turn promotes market sustainability and growth. 

Market Scope

Daratumumab Industry: Dynamics & Restrains

Market opportunity:

We Market Research: Daratumumab Dashboard

Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.

Daratumumab Segmentation

Market- By Indication Analysis

By Indication, the Daratumumab Market is Categories into Multiple Myeloma, AL Amyloidosis. The Multiple Myeloma segment accounts for the largest share of around 68% in 2024.

Rising multiple myeloma incidence rates, Daratumumab's clinical efficacy, regulatory approvals for the drug's use in multiple myeloma, and the increasing need for efficient treatments to enhance patient outcomes and quality of life are the factors driving the global market for Daratumumab.

The following segments are part of an in-depth analysis of the global Daratumumab market:

Daratumumab Industry: Regional Analysis

North America Market Forecast

North America dominate the Daratumumab Market with the highest revenue generating market with share of more than 48%. In North America the Daratumumab industry is driven by a robust healthcare infrastructure and the early uptake of novel medicines in the United States and Canada. The existence of significant pharmaceutical businesses dedicated to cancer therapies expedites the expansion of the industry.

Europe Market Statistics

Europe is the second largest region in Daratumumab Market. The growth of the Daratumumab market is driven by the rising incidence of multiple myeloma and the favorable reimbursement practices in Germany and France. Academic institutions and pharmaceutical corporations working together promote research and development, which drives the market.  

Asia Pacific Market Forecasts

Asia Pacific is expected to be the fastest-growing regional segment of the Daratumumab market during the forecast period. In the Asia Pacific region, the market for Daratumumab is being driven by rising awareness of cancer treatment choices as well as improved healthcare spending in China and Japan. The industry is growing as a result of major player’s investments to increase their market presence in developing nations like India.

Key Market Players 

The Daratumumab Market is dominated by a few large companies, such as

·         Janssen Pharmaceuticals

·         Other

1.      Global Daratumumab Market Introduction and Market Overview

1.1.    Objectives of the Study

1.2.    Global Daratumumab Market Scope and Market Estimation

1.2.1. Global Daratumumab Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)

1.2.2. Global Daratumumab Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034

1.3.    Market Segmentation

1.3.1. Indication of Global Daratumumab Market

1.3.2. Distribution Channel of Global Daratumumab Market

1.3.3. End User of Global Daratumumab Market

1.3.4. Treatment Setting of Global Daratumumab Market

1.3.5. Region of Global Daratumumab Market

2.      Executive Summary

2.1.    Global Daratumumab Market Industry Trends under COVID-19 Outbreak

2.1.1. Global COVID-19 Status Overview

2.1.2. Influence of COVID-19 Outbreak on Global Daratumumab Market Industry Development

2.2.    Market Dynamics

2.2.1. Drivers

2.2.2. Limitations

2.2.3. Opportunities

2.2.4. Impact Analysis of Drivers and Restraints

2.3.    Pricing Trends Analysis & Average Selling Prices (ASPs)

2.4.    Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.

2.5.    Porter’s Five Forces Analysis

2.5.1. Bargaining Power of Suppliers

2.5.2. Bargaining Power of Buyers

2.5.3. Threat of Substitutes

2.5.4. Threat of New Entrants

2.5.5. Competitive Rivalry

2.6.    Value Chain / Ecosystem Analysis

2.7.    Russia-Ukraine War Impacts Analysis

2.8.    Economic Downturn Analysis

2.9.      Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Region

3.      Global Daratumumab Market Estimates & Historical Trend Analysis (2019 - 2023)

4.      Global Daratumumab Market Estimates & Forecast Trend Analysis, by INDICATION

4.1.    Global Daratumumab Market Revenue (US$ Mn) Estimates and Forecasts, by INDICATION, 2019 to 2034

4.1.1. Multiple Myeloma

4.1.2. AL Amyloidosis

5.      Global Daratumumab Market Estimates & Forecast Trend Analysis, by Distribution Channel

5.1.    Global Daratumumab Market Revenue (US$ Mn) Estimates and Forecasts, by Distribution Channel, 2019 to 2034

5.1.1. Hospital Pharmacies

5.1.2. Retail Pharmacies

5.1.3. Online Pharmacies

6.      Global Daratumumab Market Estimates & Forecast Trend Analysis, by End-user

6.1.    Global Daratumumab Market Revenue (US$ Mn) Estimates and Forecasts, by End-user, 2019 to 2034

6.1.1. Hospitals & Clinics

6.1.2. Ambulatory Surgical Centers

6.1.3. Cancer Research Centers

7.      Global Daratumumab Market Estimates & Forecast Trend Analysis, by TREATMENT SETTING

7.1.    Global Daratumumab Market Revenue (US$ Mn) Estimates and Forecasts, by End-user, 2019 to 2034

7.1.1. Monotherapy

7.1.2. Combination Therapy

8.      Global Daratumumab Market Estimates & Forecast Trend Analysis, by Region

8.1.    Global Daratumumab Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034

8.1.1. North America

8.1.2. Europe

8.1.3. Asia Pacific

8.1.4. Middle East & Africa

8.1.5. South America

9.      North America Daratumumab Market: Estimates & Forecast Trend Analysis

9.1.    North America Daratumumab Market Assessments & Key Findings

9.1.1. North America Daratumumab Market Introduction

9.1.2. North America Daratumumab Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

9.1.2.1.   By INDICATION

9.1.2.2.   By Distribution Channel

9.1.2.3.   By End-user

9.1.2.4.   By TREATMENT SETTING

9.1.2.5.   By Country

9.1.2.5.1.     The U.S.

9.1.2.5.2.     Canada

9.1.2.5.3.     Mexico

10.  Europe Daratumumab Market: Estimates & Forecast Trend Analysis

10.1.  Europe Daratumumab Market Assessments & Key Findings

10.1.1.   Europe Daratumumab Market Introduction

10.1.2.   Europe Daratumumab Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

10.1.2.1.    By INDICATION

10.1.2.2.    By Distribution Channel

10.1.2.3.    By End-user

10.1.2.4.    By TREATMENT SETTING

10.1.2.5.    By Country

10.1.2.5.1. Germany

10.1.2.5.2. U.K.

10.1.2.5.3. France

10.1.2.5.4. Italy

10.1.2.5.5. Spain

10.1.2.5.6. Russia

10.1.2.5.7. Rest of Europe

11.  Asia Pacific Daratumumab Market: Estimates & Forecast Trend Analysis

11.1.  Asia Pacific Market Assessments & Key Findings

11.1.1.   Asia Pacific Daratumumab Market Introduction

11.1.2.   Asia Pacific Daratumumab Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

11.1.2.1.    By INDICATION

11.1.2.2.    By Distribution Channel

11.1.2.3.    By End-user

11.1.2.4.    By TREATMENT SETTING

11.1.2.5.    By Country

11.1.2.5.1. China

11.1.2.5.2. Japan

11.1.2.5.3. India

11.1.2.5.4. Australia

11.1.2.5.5. South Korea

11.1.2.5.6. ASEAN

11.1.2.5.7. Rest of Asia Pacific

12.  Middle East & Africa Daratumumab Market: Estimates & Forecast Trend Analysis

12.1.  Middle East & Africa Market Assessments & Key Findings

12.1.1.   Middle East & Africa Daratumumab Market Introduction

12.1.2.   Middle East & Africa Daratumumab Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

12.1.2.1.    By INDICATION

12.1.2.2.    By Distribution Channel

12.1.2.3.    By End-user

12.1.2.4.    By TREATMENT SETTING

12.1.2.5.    By Country

12.1.2.5.1. U.A.E.

12.1.2.5.2. Saudi Arabia

12.1.2.5.3. Egypt

12.1.2.5.4. South Africa

12.1.2.5.5. Rest of Middle East & Africa

13.  South America Daratumumab Market: Estimates & Forecast Trend Analysis

13.1.  South America Market Assessments & Key Findings

13.1.1.   South America Daratumumab Market Introduction

13.1.2.   South America Daratumumab Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

13.1.2.1.    By INDICATION

13.1.2.2.    By Distribution Channel

13.1.2.3.    By End-user

13.1.2.4.    By TREATMENT SETTING

13.1.2.5.    By Country

13.1.2.5.1. Brazil

13.1.2.5.2. Argentina

13.1.2.5.3. Colombia

13.1.2.5.4. Rest of South America

14.  Competition Landscape

14.1.  Global Daratumumab Market Competition Matrix & Benchmarking, by Leading Players / Innovators / Emerging Players / New Entrants

14.2.  Global Daratumumab Market Competition White Space Analysis, By End-user

14.3.  Global Daratumumab Market Competition Heat Map Analysis, By End-user

14.4.  Global Daratumumab Market Concentration & Company Market Shares (%) Analysis, 2022

15.  Company Profiles

15.1.                     Janssen Pharmaceuticals

15.1.1.   .Company Overview & Key Stats

15.1.2.   Financial Performance & KPIs

15.1.3.   Product Portfolio

15.1.4.   Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below 

15.2.      Others

16.  Research Methodology

16.1.  External Transportations / Databases

16.2.  Internal Proprietary Database

16.3.  Primary Research

16.4.  Secondary Research

16.5.  Assumptions

16.6.  Limitations

16.7.  Report FAQs

17.  Research Findings & Conclusion